Citations

Institution: Mayo Clinic Clear

Showing 10 of 108094 citations.

Bupivacaine-Meloxicam Extended-Release Solution Compared with a Standard Periarticular Injection in Primary Total Knee Arthroplasty
Salmons, Harold I. , Amundson, Adam W. , Duncan, Christopher M. , Mallinger, Benjamin D, Couch, Cory G., Pagnano, Mark W., Trousdale, Robert T. , Abdel, Matthew P. , Larson, Dirk R. , Mallinger, Benjamin D , Trousdale, Robert T , Abdel, Matthew P , Pagnano, Mark W.

Journal of Bone and Joint Surgery | July 25, 2025 | Volume: 107 | Issue: 17 | Pages: 1918-1925

10.2106/jbjs.25.00086 | PMID 40711999 Get It

Background: The U.S. Food and Drug Administration has approved a bupivacaine and meloxicam extended-release (ER) intra-articular injection for pain during total knee arthroplasty (TKA). However, the real-world evidence with regard to analgesic efficacy of that medication has been limited. This randomized clinical trial investigated the efficacy of this new medication compared with our standard periarticular injection for postoperative analgesia after primary TKA. Methods: Eligible patients undergoing primary, unilateral TKA for osteoarthritis at our academic center were enrolled. Patients were blinded and were randomized 1:1 to the bupivacaine-meloxicam ER (ZYNRELEF) injection group or the standard injection (ropivacaine, ketorolac, epinephrine) control group. A standardized, multimodal analgesic pathway was implemented. Numeric Rating Scale (NRS) pain scores and tallies of opioid consumption were collected. The primary outcome was the area under the curve (AUC) for NRS pain, adjusted for opioid consumption, over 72 hours. The minimal clinically important difference was considered to be 30%. Power analysis determined a minimum of 44 patients per group. The final groups included 53 patients in the experimental group and 48 patients in the control group. Results: Similar postoperative analgesia was observed, with an AUC for the adjusted NRS pain score up to 72 hours of 331 in the experimental group and 373 in the control group (p = 0.09). The mean maximum NRS pain scores were similar and reflected good, but not complete, analgesia. Scores were 3 to 5 on the day of the surgery, 4 to 6 on postoperative day (POD) 1, 5 to 6 on POD 2, and 4 to 5 on POD 3 (p > 0.05). One patient in the experimental group and 2 patients in the control group had early postoperative complications, none of which was deemed to be related to the analgesic choice. Conclusions: This randomized clinical trial demonstrated similar analgesia with a bupivacaine-meloxicam ER solution and a standard periarticular injection up to 72 hours after primary TKA. Cost, reimbursement, and convenience may ultimately prove to be more important than analgesic differences when choosing between these 2 effective options for managing postoperative pain. Level of Evidence: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
Monoclonal Gammopathy in ANCA-Negative Pauci-Immune Crescentic GN
Vargas-Brochero, Maria J. , Buglioni, Alessia , Mekraksakit, Poemlarp , Thongprayoon, Charat , Inácio, António , Fervenza, Fernando C. , Zand, Ladan , Domingues, Patricia , Zand, Ladan , Fervenza, Fernando C , Mekraksakit, Poemlarp , Thongprayoon, Charat , Buglioni, Alessia

Kidney360 | July 25, 2025 | Volume: 6 | Issue: 12 | Pages: 2219-2228

10.34067/kid.0000000902 | PMID 40711824 Get It

Key Points Our study found a high prevalence of monoclonal gammopathy (MG) in patients diagnosed with ANCA-negative pauci-immune crescentic GN. Patients with MG showed a higher degree of fibrosis on kidney biopsy than those without MG with higher mortality rate. Our data suggest an association between MG and ANCA-negative pauci-immune crescentic GN, emphasizing this population's need for MG testing and monitoring. Background In a small subset of patients with pauci-immune crescentic GN (PICGN), ANCA are not identified, and patients are referred to as having ANCA-negative vasculitis. The cause of the disease in this subset of patients has remained elusive. We explored the role of monoclonal gammopathy (MG) in those with ANCA-negative PICGN. Methods We conducted a retrospective study and identified patients with PICGN who had undergone ANCA and monoclonal testing. Those positive for ANCA were excluded. Results We identified 14 patients with ANCA-negative vasculitis, of whom eight (57%) tested positive for MG with a mean age of 60.3±12.2 years, 75% were female, and with a mean serum creatinine of 4.3±1.92 mg/dl. The most common monoclonal proteins were IgG ( n =4, 50%) and kappa ( n =4, 50%). One patient had diagnosis of multiple myeloma. Most common extra-renal manifestations were skin rash (leukocytoclastic vasculitis) and neuropathy. Kidney biopsy showed a higher degree of interstitial fibrosis and tubular atrophy compared with those without MG. The median follow-up time was 3.2 years, with 50% mortality in those with MG. Conclusions More than 50% of the patients with ANCA-negative PICGN have MG, and patients present with more evidence of fibrosis on kidney biopsy, with higher mortality rate observed in our cohort. Monoclonal proteins may trigger the development of PICGN; their specific role in the pathogenesis of this disease needs further investigation.
Does Femoral Rotation More Closely Mirror the Contralateral Side or a Population Mean of 15 Degrees of Anteversion? A Radiologic Study of 219 Healthy Patients
Anderson, Megan L. , Rhodes, Nicholas G. , Ahn, Jaimo , Tangtiphaiboontana, Jennifer , Hidden, Krystin A. , Dhodapkar, Meera M, Ahn, Jaimo , Tangtiphaiboontana, Jennifer , Hidden, Krystin A , Yuan, Brandon J. , Anderson, Megan L. , Dhodapkar, Meera M.

Journal of Orthopaedic Trauma | July 25, 2025 | Volume: 39 | Issue: 11 | Pages: 583-589

10.1097/bot.0000000000003048 | PMID 40709921 Get It

OBJECTIVES: To compare whether femoral version more closely mirrors the contralateral femur or a population norm estimate of 15 degrees of anteversion. METHODS: Design: Radiologic observational study. Setting: Level I Trauma Center. Patient Selection Criteria: Patients with no history of anatomy-altering femoral injury who underwent bilateral lower extremity computed tomography scans. Outcome Measures and Comparisons: Computed tomographies were analyzed to measure femoral version on each side. The asymmetry in femoral version between left and right in each patient (interfemoral rotational variance [IRV]) was recorded. The difference of each femur's version from a proposed population mean of 15 degrees of anteversion was also recorded. RESULTS: A total of 219 patients with a mean femoral version of 14.9 degrees ± 10.5 degrees of anteversion were included. Mean IRV was 5.3 degrees, compared with 8.2 degrees of mean variation from the population norm of 15 degrees of anteversion (P < 0.001). Five percent of patients had IRV >15 degrees compared with 15% that had femoral rotation >15 degrees from the population mean of 15 degrees (P < 0.001). CONCLUSIONS: In the setting of a comminuted diaphyseal femur fracture, knowledge of the appropriate target for restoration of rotational alignment is critical. This radiologic cohort study found that on average, femoral version more closely mirrors an individual patient's contralateral femur as opposed to a population norm of 15 degrees of anteversion.
Same-Day Hospital Discharge Is Feasible for a Variety of Urologic Surgeries When Using a Virtual Hybrid Care Hotel
Hampton, Sarah, Perry, Alan G., Kumar, Neal, Hochwald, Alex, Ma, R. , Pak, Raymond W., Petrou, Steven P. , Thiel, David D. , Nazario, Maura, Pathak, Ram A. , Hochwald, Alex P, Ma, Renny, Dora, Chandler , Ma, Renny, Broderick, Gregory A. , Lyon, Timothy D. , Chadha, Ryan

Urology Practice | July 25, 2025 | Volume: 12 | Issue: 6 | Pages: 683-690

10.1097/upj.0000000000000879 | PMID 40709932 Get It

Off-pore Nucleoporin sPOM121 Transcriptionally Propels β-Catenin–driven Tumor Progression and Immune Escape in Prostate Cancer
Kirthika, Perumalraja , Jawalagatti, Vijayakumar , Li, Peiyao , Xu, Michael , Carceles‐Cordon, Marc , Ertel, Adam , Quinn, S. Aidan , Petrylak, Daniel P. , Orme, Jacob J. , Dehm, Scott M. , Heath, Elisabeth I. , Cordon‐Cardo, Carlos , Zhu, Shijia , Domingo‐Domenech, Josep , Rodríguez-Bravo, Verónica , Antonarakis, Emmanuel S , Heath, Elisabeth I , Pandey, Mukesh K , Cordon-Cardo, Carlos , Huang, Rui , Dong, Haidong , Zhu, Shijia , Domingo Domenech, Josep M , Rodriguez-Bravo, Veronica , Dehm, Scott M , Kirthika, Perumalraja , Jawalagatti, Vijayakumar , Antonarakis, Emmanuel S. , Pandey, Mukesh K. , Huang, Haojie , Dong, Haidong

Cancer Discovery | July 25, 2025 | Volume: 15 | Issue: 11 | Pages: 2374-2396

10.1158/2159-8290.cd-25-0629 | PMID 40709833 Get It

Abstract The roles of nucleoplasm-residing nucleoporins (NUP) in solid tumors, including prostate cancer, remain unknown. In this study, we reveal the clinical significance and mechanistic role of the off-pore NUP, soluble POM121 (sPOM121), as a crucial transcriptional regulator that enhances the aggressiveness of metastatic prostate cancer. Using orthogonal methodologies in human samples, sPOM121 was identified as the predominantly expressed nucleoplasmic NUP in prostate cancer. Unbiased proteomic and epigenomic studies demonstrate that sPOM121, through its C-terminus, interacts with the chromatin remodeler SMARCA5 at gene promoter sites and localizes at nuclear condensates, reprogramming gene expression. Indeed, sPOM121 regulates a distinct oncogenic gene network, including β-catenin, leading to prostate cancer progression and immune evasion. Importantly, targeting the sPOM121/β-catenin axis in patient-derived preclinical and syngeneic mouse models halts prostate cancer aggressiveness and enhances antitumor immunity. Taken together, these findings reveal previously unknown actionable reprogramming functions of off-pore NUPs in solid tumors. Significance: This study uncovers how oncogenic signaling programs are transcriptionally heightened by the NUP sPOM121 in metastatic prostate cancer. Localization of sPOM121 at active transcriptional nuclear condensates propels disease progression and immune evasion, offering novel anticancer therapeutic opportunities.
Inhibition of histone deacetylase 3 in dental mesenchyme regulates the development of tooth root
Niibe, Kunimichi , Begun, Dana L., Doi-Fujimura, Kanna, Nagasaki, Atsuhiro , Zars, Elizabeth L. , Li, Xiaodong , Taylor, Earnest L., MacDougall, Mary , Zars, Elizabeth, Egusa, Hiroshi , Westendorf, Jennifer J.

Journal of Bone and Mineral Research | July 25, 2025 | Volume: 40 | Issue: 10 | Pages: 1177-1187

10.1093/jbmr/zjaf102 | PMID 40709765 Get It

Abstract Studies on human and animal models have demonstrated a complex molecular regulatory network between the dental mesenchyme and epithelium governing tooth development. However, epigenetic regulation of tooth development is largely unexplored. This study aimed to elucidate the relationship between epigenetic modifiers and dental root development using mice deficient in histone deacetylase 3 (Hdac3) under the control of the osterix promoter (Osx-Cre/Hdac3fl/fl or Hdac3-CKOosx). We observed tooth root size and histology in Hdac3-CKOosx mice. Dental pulp progenitor cells (DPCs) were isolated from lower incisors, and calcification and gene expression were assessed. Hdac3 depletion in osterix-expressing dental pulp stem cells, including odontoblasts, caused a progressive postnatal obstruction, resulting in relatively short roots and small root apices of the first molar. Mild degeneration was observed during the development of dentin and cementum structures. Dentin and cementum had uneven borders and showed disordered H&E staining in Hdac3-CKOosx mice that had a thin cementum compared to that of WT mice. Hdac3 inhibition/deletion in dental pulp stem cells probably influenced Msh homeobox 1 (Msx1) and Col1a1 expression in the early developmental stage, thereby driving differentiation in DPCs. Subsequently, Msx1, Col1a1, and osteocalcin expression were remarkably downregulated during calcification. Deletion or inhibition of Hdac3 in conditional KO dental pulp stem cells cultured in mineralization medium resulted in aberrant cell cycle control, and the early stages of maturation of DPCs and odontoblasts were inhibited. Inhibition of Hdac3 in cementocytes also restricted their proliferation and calcification. These results suggested that the deletion or inhibition of Hdac3 in the dental mesenchyme may cause development and maturation deficiency of tooth root.
Coronary function testing vs angiography alone to guide treatment of angina with non-obstructive coronary arteries: the ILIAS ANOCA trial
Boerhout, Coen K.M. , Namba, Hanae F , Liu, Tommy , Damman, Peter , Meuwissen, Martijn , Ong, Peter , Sechtem, Udo , Appelman, Yolande , Berry, Colin , Escaned, Javier , Henry, Timothy D. , Delewi, Ronak, Piek, Jan J., Hoef, Tim P. van de , Damman, Peter , Meuwissen, Martijn , Ong, Peter , Appelman, Yolande , Berry, Colin , Escaned, Javier , Lerman, Amir , van der Harst, Pim , van de Hoef, Tim P , Beijk, Marcel A.M. , Lerman, Amir , Harst, Pim van der , Delewi, Ronak , Piek, Jan J

European Heart Journal | July 25, 2025 | Volume: 46 | Issue: 42 | Pages: 4396-4406

10.1093/eurheartj/ehaf580 | PMID 40796241 Get It

Abstract Background and Aims Invasive coronary function testing (CFT) identifies coronary vasomotor disorders in up to 90% of patients with angina with non-obstructive coronary arteries (ANOCA). The ILIAS ANOCA trial hypothesized that routine ad hoc CFT would be feasible, safe, and effective in providing an early, comprehensive diagnosis. Additionally, it was anticipated that combining CFT with a disease-specific treatment protocol would significantly improve quality of life in ANOCA patients compared with standard care. Methods After excluding patients with obstructive coronary artery disease (CAD) during clinically indicated invasive coronary angiography (ICA), eligible patients underwent CFT and were randomized to either the standard care group, where CFT results remained blinded, or the intervention group, where CFT results were disclosed along with a tailored medical therapy protocol. The primary outcome was the mean difference in the within-subject change in Seattle Angina Questionnaire summary score (SAQSS) between groups from baseline to a follow-up of 6 months. The trial is registered with the International Clinical Trials Registry Platform (NL-OMON20739). Results A total of 255 patients consented, of whom 153 patients (60%) without CAD underwent CFT and were randomized 1:1 to the standard care (n = 76) or intervention group (n = 77). All CFT procedures were successful without adverse events. A vasomotor disorder was identified in 120 patients (78%). At 6-month follow-up, the SAQSS improved significantly in the intervention group compared with the control group, with an intervention effect of 9.4 units (95% confidence interval 3.9–14.9, P = .001). There were no major adverse cardiac events at the 6-month follow-up. Conclusions Routine CFT during the initial ICA was feasible, safe, and had high diagnostic yield. Implementing a pragmatic CFT protocol combined with a disease-specific treatment protocol significantly improved disease-related quality of life in patients with ANOCA compared with standard care.
Treatment Times and In-Hospital Mortality Among Patients with ST-Elevation Myocardial Infarction Throughout the Waves of the COVID-19 Pandemic: Lessons Learned
Zègre‐Hemsey, Jessica K. , Goyal, Abhinav , Poudel, Ram , Thomas, Kathie , Ali, Murtuza J., Best, Patricia J.M. , Bieniarz, Mark, Fonarow, Gregg C. , French, William J. , Henry, Timothy D. , Hong, Haoyun, Jollis, James G. , Redlener, Michael , Spier, Travis, Stone, Harper, Wahab, Feras, Wang, Lanjing , Jacobs, Alice K. , Granger, Christopher B.

COVID | July 25, 2025 | Volume: 5 | Issue: 8 | Pages: 114

10.3390/covid5080114 Get It

Previous studies about the COVID-19 pandemic on STEMI patient outcomes have conflicting results. It remains unclear if this may be attributed to regional differences and/or differences during COVID-19 wave periods. Using the American Heart Association Get With The Guidelines–Coronary Artery Disease registry data, we evaluated (1) time metrics related to STEMI system goals and (2) regional variation in STEMI incidence and in-hospital mortality during pandemic wave time periods. The study included all patients 18–100 years old admitted with STEMI (n = 72,516) to 1 of 435 American Heart Association Get With The Guidelines–Coronary Artery Disease hospitals (1 October 2019–31 December 2021). Of these, 70.8% were male and 73.0% non-Hispanic White, with a median age of 63 (IQR 18) years. Compared to pre-pandemic time frames, patients with STEMI had a higher risk profile, delayed time to treatment, were treated with fibrinolytic therapy or primary PCI, and were transferred for primary PCI at similar rates, and had higher adjusted in-hospital mortality (during the second wave in the South and Midwest). Preservation of STEMI systems of care resulted in an overall lower in-hospital mortality rate than predicted, although opportunities exist to improve treatment delays. Regional differences in mortality rates require further study.
Response to Letter to the Editor Concerning the Article “Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation”
Ibrahim, Ramzi , Lim, Ghee K., Mee, Xuan Ci , Abdelnabi, Mahmoud , Habib, Eiad , Lee, Justin Z. , Lester, Steven J., Scott, Luis R. , Sorajja, Dan , Ayoub, Chadi , Pham, Hoang N, Mee, Xuan Ci , Ibrahim, Ramzi , Ibrahim, Ramzi , Lim, Ghee K., Pham, Hoang N., Farina, Juan M. , Lee, Kwan , Arsanjani, Reza

Journal of Cardiovascular Electrophysiology | July 25, 2025 | Volume: 36 | Issue: 8 | Pages: 2105-2106

10.1111/jce.70030 | PMID 40709569 Get It

Validation of Current Staging Systems in HNCSCC : A Multinational Cohort Study
Girardi, Fábio Muradás , Machado, Cristian David Cardona , Wysong, Ashley, Ran, Nina A., Granger, Emily , Koyfman, Shlomo A. , Vidimos, Allison T. , Carr, David R. , Shahwan, Kathryn T., Hirotsu, Kelsey E. , Carter, Joi B., Mangold, Aaron R. , Brodland, David G., Zitelli, John A. , Willenbrink, Tyler J., Jambusaria‐Pahlajani, Anokhi , Nijhawan, Rajiv I. , Ruiz, Emily S. , Cañueto, Javier , Granger, Emily E , Shahwan, Kathryn T , Willenbrink, Tyler J , Mangold, A R , Wagner, Vivian Petersen , Wysong, Ashley , Carr, David R., Carucci, John A. , Srivastava, Divya

Head & Neck | July 25, 2025 | Volume: 47 | Issue: 12 | Pages: 3385-3393

10.1002/hed.28259 | PMID 40709408 Get It

ABSTRACT Importance Risk stratification of cutaneous squamous cell carcinoma (CSCC) is central to effective management. Despite advancements in the 8th edition of the American Joint Committee on Cancer (AJCC8) staging system, the distinctiveness of T‐stages remains limited. Objective To evaluate the effectiveness of the Brigham and Women's Hospital (BWH) and the AJCC8 staging systems in predicting poor outcomes in head and neck (HN) CSCC. Design A retrospective, multinational cohort study of CSCCs diagnosed between January 10, 1991, and December 31, 2023. Setting Twelve centers across the United States (10), Spain (1), and Brazil (1). Participants Patients with invasive CSCC who underwent curative‐intent surgical treatment. Exclusions included cases of lip CSCC, cases with prior HN cancer with associated regional disease, patients with a history of chemotherapy/radiotherapy for other HN neoplasms, and recurrent primary tumors. Exposure Tumors were staged according to both the AJCC8 TNM staging system and the BWH tumor classification. Main Outcomes and Measures Local recurrence (LR), nodal recurrence (NR), distant recurrence (DR), and disease‐specific death (DSD). Results A total of 9852 excised tumors from 3168 patients were included. The 2 systems had comparable monotonicity and homogeneity. Significant differences could be observed in 5‐year cumulative incidence for DSD in both BWH and AJCC8, and also for LR in BWH. Higher T‐stages exhibited similar curves regarding NR and DR for both AJCC8 and BWH staging systems. Overall, we observed high specificity and NPV, low sensitivity and PPV, and moderately high c‐indices for both the BWH and AJCC8 staging systems in predicting the main outcomes for HNCSCC. Conclusion and Relevance Current AJCC8 and BWH staging systems can accurately predict survival in HNCSCC, although there are still important characteristics to be addressed in future staging systems for better stratification according to the other main outcomes.